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ABSTRACT 
 
Infection following hip arthroplasties can present a diagnostic challenge. No test is 100 
% sensitive and 100% specific; this prospective study was undertaken to evaluate the 
utility of FDG-PET imaging for diagnosing infected joint replacements. 24 hip joint 
replacements were studied prospectively and we have complete diagnoses with clinical 
signs and symptoms, laboratory tests, radiography, joint aspiration, radionuclide 
imaging including FDG-PET, and histopathologic examination. 11 of 24 prostheses 
were infected. The sensitivity and specificity of PET for detecting infection associated 
with prostheses were 64.3% and 64.7% respectively, in our study. 
FDG imaging is not useful in patients with suspected prosthetic infection as a screening 
test. 
Key words: infection, septic and aseptic loosening, failed prostheses replacements, 
FDG-PET. 
 
 
RESUMEN  
 
Objetivo. Las causas más frecuentes de prótesis dolorosas son la movilización o 
aflojamiento aséptico, y la movilización séptica o infección. Una infección protésica 
siempre constituye un reto diagnóstico puesto que, salvo ante la presencia de fístula u 
otros signos de infección evidente, no existe ninguna prueba definitiva (sensibilidad y 
especificidad del 100%) para el diagnóstico prequirúrgico. El objetivo de nuestro 
estudio fue intentar conseguir un protocolo diagnóstico eficaz y eficiente de 
movilización protésica. 
Material y método. Para ello se estudiaron 24 recambios protésicos de cadera 
prospectivamente mediante clínica, estudios de laboratorio, radiografía, tomografía por 
emisión de positrones con 2-18F-fluoro-2-desoxi-D-glucosa (18FDG-PET), cultivo de 
líquido articular y de biopsia y estudio histopatológico. 
Resultados. 11 de las 24 prótesis estaban infectadas. La sensibilidad y especificidad de 
la tomografía por emisión de positrones (PET) para detectar infección protésica fue del 
63,6 y del 61,5%, respectivamente. 
Conclusiones. La imagen 18FDG-PET no permite discernir, en nuestras manos, entre 
movilización séptica y aséptica protésica, por lo que en pacientes con sospecha de 
infección tiene un valor limitado como técnica de cribaje diagnóstico. 
Palabras clave: infección, movilización protésica séptica y aséptica, recambios 
protésicos, 18FDG-PET. 
 
 
 
INTRODUCTION 
 
As Laskin stated in 1999, “Infection as the main cause of a painful hip prosthesis (THP) 
should prevail over all hypotheses and before any other cause, we should think of a low 
profile infection” In the same way, various studies have suggested that a painful knee 
prosthesis (TKP) should be considered infectious until another cause is shown.1-5
The infection rate in primary TKPs varies between 1 and 4%,6 and is the most common 
cause of failure of posterior stabilised TKP.3 With respect to THPs, Hanssen and Rand 
related a rate of deep infection of 1.3% in almost 25,000 patients who underwent this 
operation in the Mayo Clinic (1969-1996); most of the infections took place during the 
first three months, with a tendency to decrease to a constant figure of 2% over the two 
years of evolution. For the TKPs, the figure rises to 2.5% of a total of 16,000 
arthroplasties.7 Moreover, it should be taken into account that the percentage of 
recurrence of infection, after replacing a septic prosthesis, is higher than after an aseptic 
mobilisation (for these latter cases around 3.2% for revision of the THPs and 5.6% for 
the TKPs) and especially after primary prosthesis surgery, since it goes on to reach 
percentages, according to the series, from 10 to 26% of infection with an increase in risk 
as the years go by.8 
 
Acute infection of an arthroplasty is obvious, but the diagnosis of sub-acute or chronic 
infections is more problematic6, 9-14 and supposes a bigger challenge for the 
orthopaedist; they are not generally associated with systemic symptoms of infection and 
often go unnoticed. To this has to be added the different management of the two types 
of mobilisations (prosthetic replacement in a single operation for aseptic mobilisations 
or in two halves with/without local antibiotic release systems and prolonged post-
operative systemic antibiotherapy, with/without allografts or even arthrodesis, resection 
arthroplasty... for prosthetic infections), which can lead to failure of the prosthetic 
replacement (if it had) if the diagnosis is not correct, with the socioeconomic 
consequences that this entails8, 15-17 (fig. 1). The estimated cost of each treatment of an 
infected arthroplasty in 1995 was between 50-60 thousand dollars, which in the U.S. 
means a national expenditure of between 200 and 250 million dollars annually.18 The 
estimated expenditure in the United Kingdom, with approximately 50,000 THP 
annually and around 500 cases of infection in 1990, is £16 million per year.8 
 
The differential diagnosis between septic and aseptic loosening is therefore 
fundamental, both for choosing the correct treatment and for assessing its evolution and, 
sometimes, the diagnosis of safety is not reached until removal and study of the 
prosthetic material. Clinical suspicion (pain, local signs, general signs), radiology, 
scintigraphy, laboratory tests, articular punction-biopsy, other complementary tests or 
the combination of them do not reach 100% diagnostic sensitivity (Se) and specificity 
(Sp) values, and there is no universally accepted diagnostic protocol. Although the rate 
of infection has gradually decreased in the last thirty years,8, 15, 16, 19-23 the problem 
continues to be significant because of the increasing number of arthroplasties, mainly 
due to the increase in the average age of the population. 
 
Imaging tests with radiopharmaceutical agents can provide us with diagnosis of the 
prosthetic mobilisation; however, its use is limited due to the cost of the tests, the time 
necessary to perform them and especially, because they do not always give sufficient Se 
and Sp levels as diagnostic tests.16, 24 Basically, for a painful prosthesis, the 
radiopharmaceutical agents used are: Technetium (99mTc-MDP, 99mTc-HMPAO, 99mTc-
IGH), Gallium (67Ga) and Indium (111In-oxine, 111In-IGH). 
 
When the study was carried out with 111In-oxine in cases which were positive for 99mTc-
MDP, a diagnostic Se for infection of 100% and Sp of 98% was achieved in some 
series.25, 26 The use of human immunoglobulin labelled with 99mTc or with 111In seems to 
improve the results of 111In-IGH with respect to the combination of 99mTc-MDP + 
leucocytes-111In-oxine, even as an isolated test, but there are no comparative studies of 
both techniques in prosthetic infections exclusively, so their systematic use in daily 
practice is not recommended. 
 
At the present time, the recommended sequence is the study with 99mTc-MDP + 
leucocytes-111In-oxine, but without considering the results as definitive,15, 16, 24, 27-31 and 
it is especially useful in those cases where the laboratory tests or cultures for taking of 
previous antibiotics are equivocal.32 
 
The use of the combination of dynamic bone scintigraphy (3 phases) + labelled 
leucocytes is accepted as a method which has good diagnostic efficacy (between 79 and 
100%) for infectious processes in the peripheral skeleton at the clinical level.33, 34 
However, the efficacy of this strategy decreases in the presence of: 
1. Low-grade/subclinical infections (lower Se).35-37 
2. Infection of adjacent soft tissues because of limited image resolution (lower Se 
and Sp).27, 36 
3. Involvement of the central skeleton due to the presence of normal bone marrow 
and the possible presence of “cold lesions” or photopenic areas (lower Se and 
Sp).27, 30, 35, 36, 38, 39 
4. Trauma or surgical operations due to the presence of ectopic haemopoietic bone 
marrow foci (lower Sp).27, 36 
5.  
Furthermore, if in some infection situations, two and up to three different scintigraphy 
techniques are required to increase the diagnostic Se and/or Sp, it is logical to think that 
this strategy is not very practical, since it raises the costs and the time consumed and 
increases the patients’ exposure to radiation; it is therefore important to find a method 
with the same Se and Sp in a single process. 
 
Because of all this, positron emission tomography with 2-18F-fluoro-2-deoxy-D-glucose 
(18FDG-PET) is being proposed as a promising imaging technique in the study of 
musculoskeletal infections27 and within these, in the field of prosthetic infection.40-45 
The objective of this study is to be able to establish an effective and efficient diagnostic 
protocol for prosthetic mobilisation through the prospective evaluation of clinical, 
microbiological, imaging (including 18FDG-PET) and histopathological findings and the 
relationship between them. 
 
 
MATERIAL AND METHOD 
 
A prospective review was carried out on 24 hip prosthesis replacements with more than 
six months evolution from their implantation (in different hospital centres), which were 
performed in our centre in a period of approximately four years (1999-2003). These 
constituted the case group. Of the 24 patients, 12 were men and 12 women, with ages 
between 37 and 81 years (mean of 67.8 years). The replacement made was one of the 
components (cotyloid cup or stem) or both. In all patients, there were clinical and/or 
radiological criteria for prosthetic mobilisation, although not always for septic 
loosening, so a battery of tests was requested on all patients according to the protocol: 
full blood count, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), 
radiography of anteroposterior (AP) hips, positron emission tomography (PET) of the 
hips, joint fluid and biopsy sample culture and polymorphonuclear leukocyte (PMN) 
count in intraoperative biopsy (frozen sections). Those patients with any pathology 
which could alter the laboratory tests, cell composition of the prosthetic interface to be 
studied or imaging tests were previously removed from the sample. Likewise, those 
patients in whom the battery of scheduled tests could not be completed or in whom a 
post-operative diagnosis of the type of mobilisation (septic or aseptic) could not be 
reached with certainty were excluded. This definitive diagnosis, which constitutes our 
diagnostic gold standard, is based on confirmation of the infection on the basis of 
modified Tsukayama et al’s criteria, 1996: 
1. The same microorganism grows in at least two cultures obtained by aspiration 
and/or debridement. 
2. The microorganism grows in a single culture associated with one of these three 
situations: 
a) Fistula with active drainage. 
b) Purulent drainage at the time of debridement (“poor appearance” of the 
tissues is not sufficient). 
c) Evidence of acute or subacute purulent inflammation on biopsy of 
intraarticular tissue. 
 
It was necessary to establish this definitive diagnosis with complete confidence, so other 
paragraphs were added to Tsukayama’s criteria, since the cultures have not always 
proven to be the best gold standard: 
1. Poor presurgical evolution of the prosthesis in the medium term (1 year) without 
a justified cause (decementation, dislocation, fracture, etc.) and definitive 
histopathological diagnosis of acute purulent inflammation post-surgery. 
2. Poor postsurgical evolution of the prosthesis in the medium term (1 year) 
without a justified cause (decementation, dislocation, fracture, etc.) and 
definitive histopathological diagnosis of acute purulent inflammation post-
surgery. 
 
 
 
 
Positron emission tomography equipment 
 
Patients required previous preparation, as per the Department of Nuclear Medicine 
protocol, to guarantee good imaging quality. It included a 6-8 hour fast, analysis of 
serum glucose levels and avoiding physical exercise previously. 
The radiotracer used was 18FDG, the isotope of which is a positron emitter (18F-), and 
which was obtained in a cyclotron model Cyclone 18-9-IBA. 6.2 MBq/kg was 
administered endovenously in the forearm. The recommended dose for adults is 
between 10 and 15 mCi (4-6 mCi for image acquisition in 3D), although it depends on 
the equipment. 
 
A minimum of 40 minutes elapsed after injection of the 18FDG, since it is advisable to 
wait up to 50-60 minutes to reach a maximum stable glucose incorporation rate. Oral 
and/or intravenous hydration of the patient was carried out after injection of the 18FDG, 
carrying out bladder catheterization (Foley catheter) and the administration of 
furosemide (0.25 mg/kg). In addition, in some cases, the bladder was filled 
retrogressively with physiological serum to remove possible artefacts caused by the 
activity of the 18FDG filtered in the concentrated urine over the course, serving also as 
an anatomical reference. 
 
 
Acquisition of the studies  
 
Instrumentation 
The PET tomograph used in our study was Siemens® model ECAT EXAT HR +. The 
axial view field was 15.5 cm, with a tomographic section thickness of 1 cm. It was 
acquired for 10 minutes per bed (space travelled by the bed in each movement, 13.5 
cm), with 3 beds required to completely scan the patient with THP. 
 
The emission-transmission images thus obtained were processed by OSEM iterative 
reconstruction (ordered subsets-expectation maximization: 1 iteration, 30 subsets) and 
an attenuation corrected image was obtained which allowed the standardized uptake 
value (SUV) to be calculated. The images were viewed in the different planes: axial, 
sagittal and coronal. 
 
Semi-quantitative measurements of the concentration of the radiopharmaceutical agent 
in the body were taken from the tomographic images obtained from the positron 
emission using SUV units, after control of possible sources of error, such as the system 
resolution itself, the presence of accidental coincidence or dispersion phenomena, the 
error due to dead time and that caused by the attenuation. Attenuation acquisition was 
first carried out, then the transmission image was acquired, from which we obtained the 
SUVs and finally, the emission image was acquired. 
 
The SUV was calculated from the formula: 
 
 
 
 
 
 
 
Interpretation 
 
The increased uptake foci were qualitatively analysed according to the Gruen and De 
Lee zones (figs. 2A and 2B). Semi-quantitative analysis was subsequently performed by 
obtaining the SUV (Maximum SUVs [SUVmax]) in the hypermetabolic foci of the 
regions of interest (ROI). 
 
Presurgical diagnoses of the type of mobilisation were established based on the PET 
images (visual interpretation) of each patient and divided into 3 categories: 
1. No infection (aseptic mobilisation): pattern of uptake normal (defined in the 
control group) or in any other location with an intensity similar to the 
contralateral end or similar to/less than the synovial structures or adjacent soft 
tissues. 
2. Possible infection (possible septic mobilisation): uptake in areas of normality 
with intensity much higher than the synovial structures or adjacent soft tissues or 
uptake in the prosthesis-bone interface with intensity greater than the synovial 
structures or adjacent soft tissues. 
3. Certainty of infection (septic mobilisation): uptake in the prosthesis-bone 
interface with intensity much higher than the synovial structures or adjacent soft 
tissues or fistulous tract uptake. 
 
These diagnoses were made by two independent observers (Department of Nuclear 
Medicine) without knowledge of the patients or of their clinical-radiological 
characteristics. 
  
A control group was set up which was composed of 14 patients with THP who had been 
operated on in our centre (2002-2003) consecutively, who did not present postoperative 
incidences and who also agreed to routine control radiographies, an 18FDG-PET at two 
months and a year after the arthroplasty, coinciding with their review consultations and 
laboratory tests at a year, similar to that carried out in the case patients (replacement). 
These studies served to establish the normal PET image uptake pattern and to be thus 
able to evaluate the pathological pattern. All the imaging studies, including the PET, 
were evaluated based on a series of areas or zones according to Gruen and DeLee46, 47 
for the THP, modified for this study: I-VII for the stem, A2-C2 for the femoral neck and 
A1, B and C1 for the cotyloid cup (figs. 2A and 2B). 
 
 
Statistical methods 
 
The association between qualitative variables was studied using contingency tables. 
Since the sample size per box was insufficient for asymptotic approximation using Chi-
squared tests, the significance was assessed using exact tests, calculated using the 
program Exact2xK.exe from the statistical package PEPI 4.0 [Abramson JH, 2001]. 
Computer Programs for Epidemiologists: PEPI Version 4.0. Sagebrush Press, Salt Lake 
City). For the quantitative variables, the comparison between two independent groups 
(septic and aseptic mobilisation) was performed using Mann-Whitney U tests. The 
comparison between paired data (controls at two months and one year) was carried out 
using Wilcoxon sign rank tests. Various statistical techniques were used for the 
diagnostic efficacy: 
1. For qualitative or quantitative variables already dichotomised: calculation of the 
Se, Sp and positive and negative predictive values, together with their respective 
confidence intervals. The statistical package PEPI 4.0, program Scrn.exe, was 
used for this. 
2. Determination of the diagnostic efficacy of the quantitative variables and their 
optimal cut-off point using ROC curves. The maximum Youden index was used 
as a criterion to find the optimum cut-off point. 
3. Agreement of the two observers between each other and with the gold standard: 
kappa index. The statistical package PEPI 4.0, program kappa.exe, was used for 
this. 
 
For the descriptive study and most of the statistical analyses (except those carried out 
with PEPI 4.0) the statistical package SPSS, v11.5 for Windows (SPSS inc. 1989-2002, 
Chicago-Illinois) was used. 
 
 
RESULTS 
 
We assessed which uptake areas appeared on the PET and what signal intensity 
(SUVmax) they had in the two groups. The results obtained are summarised in a table 
where the frequencies of uptake of each area are represented in percentage, as is the 
frequency with which these areas coincide with the SUVmax area and the relationship 
with the uptake of the control group for the THP (table 1). 
 
From these results, it emerges that the uptake in the cotyloid cup (A1, B and C1) looks 
like a specific pattern or is related with the mobilisation, but regardless of whether it is 
septic or aseptic. Although C1 seems to be exclusive to the aseptic loosenings, the 
sample size does not allow us to confirm this with statistical significance. The uptake in 
the neck of the prosthesis (A2 and C2) occurs in practically 100% of the controls and in 
very high percentages in both areas, both for septic and aseptic mobilisations, so they 
are not discriminative uptake areas. 
 
In the femoral stem, there was no uptake in any patient in our series of cases or of 
controls in areas 3, 5 and 6; the uptake in zones 2 and 4 is anecdotal, since there was 
only one case in each, but it drew attention because they did not appear in any control or 
in any aseptic loosening. In area 1, corresponding to the greater trochanter, it seems 
slightly more common in the mobilisations, but the percentages are inconclusive. Zone 
7, the minor-calcar trochanter, appears as a mobilisation pattern exclusively and not in 
controls, but it is a datum with little weight since it does not correspond to more than 
one case for each type of mobilisation. 
 
With respect to SUVmax from the same table (table 1), it emerges that in 73.9% of the 
cases this is located in the areas of the femoral neck, either in the external or medial 
zone; this finding also occurs in the control group, so it is not considered discriminative. 
Table 2 summarises the data on the number of uptake areas for the THPs in relation to 
each subgroup, septic and aseptic mobilisation, in case diagnostic discrimination is 
possible in relation to the number of areas. The SUVmax frequency results are also 
shown. Taking the type of mobilisation into account, it appears from this table (table 2) 
that the differences both for the number of areas and for the SUVmax do not reach 
statistical significance and are not clinically relevant. Therefore, neither the number of 
areas nor the SUVmax are useful for distinguishing between septic and aseptic 
mobilisation. 
 
We have not found any statistically significant or clinically useful relationship which 
explains the false positive (FP) or false negative (FN) results of PET imaging in the 
diagnosis of septic mobilisation: neither the number of areas of osteolysis nor the 
amount of bone stock lost (for FP); nor the presence of periosteal detachment (for FP); 
nor the presence of a specific interface, such as for example, a chronic inflammation 
reaction to a foreign body, with an abundance of giant cells (for FP); nor taking 
previous antibiotics (for FN; none of the patients wrongly diagnosed as aseptic 
mobilisation by PET had previously taken antibiotics). Therefore we must assume that 
they are the FP and FN of the test itself, inherent in it. 
  
If we perform statistical analysis of the PET as a diagnostic test of septic mobilisation in 
our series (table 3), we seen that the values produced by PET as regards the diagnostic 
efficacy are low, and do not reach good standards for its clinical application, since other 
tests have better diagnostic efficacy (table 4). 
 
 
DISCUSSION 
 
Since 1996, it has been suggested in the literature that the use of PET could be useful in 
the diagnosis of infections; the authors have based this on the observation that 
granulocytes and mononuclear cells use glucose significantly during the intense 
metabolic process in the fight against infection. This process only occurs if the white 
cells are activated by the humoral agents which take part during the infection. 
Haemopoietic bone marrow is barely seen on the FDG-PET scan because the white 
cells-neutrophils in it are, under normal conditions, in a state of inactivation.36 
 
Therefore in the first place, in order to diagnose a bone infection (osteomyelitis), we 
need the imaging method, such as FDG-PET, to be able to clearly distinguish between 
normal bone marrow and activated white cells. 
 
Secondly, the lesion should be able to be seen, whether it is an acute or chronic process. 
Thirdly, FDG, since it is a small molecule, can quickly appear in poorly perfused tissues 
in contrast with labelled granulocytes, which also means, in the latter case, delaying 
obtaining the images at least 24 hours. 
 
In fourth place, the method has a much higher spatial resolution and is itself 
“tomographic”, so it can distinguish whether the soft tissues have been affected or not, 
and it is not influenced by the presence of metallic artefacts such as happens in the case 
of magnetic resonance.27, 37, 48, 49 
 
Finally, although PET has a high cost compared with the existing alternatives, its 
efficacy is superior and the leukocyte and antibody markers are pharmaceutical 
medicinal products which are expensive in comparison to the price of the FDG. 
Moreover, in a defined area of the body (for example, thigh or knee) the study could be 
done in 15-20 minutes, unlike tumour staging studies which require much more time, 
which would lower the costs.36 
 
The shortage of publications inspired us to carry out a research project on prosthetic 
mobilisation, the diagnosis by PET and the usefulness of other tests classically used for 
such a purpose; it is presently the only study which we have found which is prospective, 
presents homogeneous case and control groups and has histopathological and 
microbiological studies in all cases. 
 
According to some authors,44, 45 since uptake does not appear in the bone-prosthesis 
interface or in aseptic mobilisations in the control groups, this should be considered as a 
very suggestive sign of infection in a painful THP. According to this criterion, the 
uptake around the femoral neck is not suggestive of infection, and for other authors the 
aseptic mobilisation has a similar pattern,42, 44 which would indicate that post-surgical 
changes (which remain for a long time) and aseptic mobilisation may be 
indistinguishable using this imaging method.44, 45 
 
Manthey et al, 2002, established the uptake of FDG in certain areas as exclusive of 
infection and differentiated them from areas of synovitis and/or aseptic loosening.40 
They established the diagnosis of non-specific synovitis when there was an increase in 
FDG uptake in the synovial structures or soft tissues around the prosthesis compared 
with the contralateral side. They spoke of aseptic loosening if the FDG uptake occurs in 
the bone-prosthesis interface with intensity less than or similar to the uptake of synovial 
structures/synovitis or soft tissues, and the diagnosis is infection if the uptake in the 
interface is much greater than in the synovial structures or soft tissues. Therefore, the 
difference between an aseptic and septic loosening is, for these authors, purely 
quantitative on a visual scale. 
 
De Winter et al, 2001, have already explained how an increase in FDG uptake in the 
interface and the pseudocapsule around an implant with aseptic loosening is possible, 
due to its containing more activated macrophages and greater proliferation of fibroblast-
like cells than the tissues around well attached prostheses. Of the 23 cases with painful 
prostheses evaluated by Manthey et al, with the first method, only 13 patients were 
operated on, and of these, a histological study was only obtained in 4 of them. The 
definitive diagnosis was verified in this study by “the surgical findings in the patients 
operated on and by follow-up to 2 years of patients who had not undergone surgery”. 
We consider that a good reference standard was not used for which we are certain that 
when synovitis is diagnosed, it is not a low profile infection, since patients with this 
diagnosis are not operated on and supposedly continue with the pain for which they 
sought medical advice (the authors do not say otherwise). Neither do we believe that it 
is easy to distinguish if this uptake in the interface or the periprosthetic (non-interface) 
uptake per se is infection or not, simply by assessment of the uptake by a visual scale; 
when we found high intensity uptake in the interface in our series, it was not always in 
septic mobilisations (fig. 3). In figure 4 we show an example of PET diagnostic failure 
with Manthey et al’s criteria in our series; the uptake pattern, according to Manthey et 
al, would correspond to synovitis and would concur in a FN, since this hip prosthesis 
was infected (positive biopsy and histopathology cultures). 
 
In our study, furthermore, all the painful prostheses were considered as mobilised 
(macro or microscopically), and therefore we do not rely on that diagnosis of 
synovitis40, 41 nor do we believe it, since it does not have a histopathologically 
confirmed basis. 
 
We did not find a pattern characteristic of septic mobilisation as opposed to aseptic as 
proposed in the literature consulted39, 40, 42, 43, 45, 50-53 in the form of high grade increased 
uptake in the bone-prosthesis interface (the biggest series recorded is that of Zhuang et 
al, 2001, with 36 mobilised TKPs and 38 mobilised THPs); moreover, neither the 
number of areas nor the SUVmax contribute anything to this differential diagnosis. This 
last statement is supported by other studies on prostheses,39, 43, 50, 54 and it had already 
been disclosed by Love et al (1994), who investigated pulmonary abnormalities,55 and 
in studies on the detection of other types of infections. 48, 56, 57 That is, it would be false 
to think that the greater the number of uptake areas, the more possibility of infection. 
Neither would the premise that a higher SUVmax corresponds to infection be true. In 
fact, in our cases, the mean number of areas in THP is 3 for aseptic mobilisations and 
less, 2.7, for the septic mobilisations. The mean SUVmax was 3.9 (0-8.5) for the aseptic 
loosenings and 4.8 (2.6-13) for the septic, with the differences being not statistically 
significant and, moreover, not clinically valuable (mean difference of less than one unit 
for the SUVmax and the area). 
 
We have not found a clear explanation for obtaining such low Se (4 FN) and Sp (5 FP) 
values with respect to the rest of the studies (table 5). Perhaps it is due to the learning 
curve and/or limited sample size, although it can be seen that the number of infections 
tested in all the series is around ten (maximum 21 combining hip and knees in Zhuang 
et al, 2001), so our series is along this line. 
  
In our opinion, and reviewing the literature, it seems that 18FDG-PET in the diagnosis of 
chronic musculoskeletal infections has greater diagnostic efficacy than the combination 
of bone scintigraphy + scintigraphy with labelled leukocytes,4 but in the case of 
prosthetic mobilisations, not only do we have to distinguish between whether there is 
infection or not, but since there is a third diagnostic category (1. infection; 2. no 
infection; 3. non-infected but mobilised prosthesis), it is not possible to establish a 
differential diagnosis with certainty; therefore we believe that there are other less costly 
tests with similar efficacy. This statement is supported by Love et al, 2001, who believe 
that although FDG imaging is exquisitely sensitive, it does not allow differential 
diagnosis in spite of the localisation. These results should not surprise us if we consider 
that FDG uptake is dependent on tissue metabolism. Inflammation and infection are 
both hypermetabolic states and, therefore, manifest as areas of increased activity. The 
combined image of a study with labelled leukocytes complemented by a bone marrow 
study (usually with 99mTc sulphur colloid) is superior to the FDG image, which in turn 
did not prove to be better than the combination of bone scintigraphy and Gallium 
citrate.25, 26, 29, 32-34, 37, 39, 58-65 
 
 
CONCLUSIONS 
 
The following conclusions emerged from our study: 
1. 18FDG-PET, in our series, did not prove to be an effective test in the presurgical 
diagnosis of prosthetic septic mobilisation. 
2. We did not find a characteristic pattern of septic or aseptic prosthetic 
mobilisation in PET imaging. 
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Figure 1. Images corresponding to the case of a prosthetic septic mobilisation after a 
first aseptic replacement. The clinical diagnosis, from radiographic and positron 
emission tomographic imaging and histopathology were clearly infection, although the 
cultures were negative. The biopsy shows abundant fibrin, granulation tissue with many 
neutrophils and detritus. Figure 1B shows giant cells with cement in their interior and 
macrophages. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2. Pattern of normality of positron emission tomography (PET) in the hip (THP) 
and knee prosthesis (TKP) control group. 2A) Diagram taking the Gruen- DeLee areas 
for THP and Ewald areas for TKP as a base. 2B) Real test in the control group. 
 
Figure 3. False positive on positron emission tomography (PET); case labelled as 
infected by PET imaging and which was not. SUVmax: maximum standardised uptake 
value. 
 
 
 
Figure 4. False negative on positron emission tomography (PET); case labelled as not 
infected by PET imaging and which was. THP: hip prosthesis; SUVmax: maximum 
standardised uptake value. 
 
 
Table 1. Frequencies of uptake in cases of hip prosthesis on pet, distributed by areas        
(gray light: > 50%; gray dark: 25-50%) 
Uptake 
zones/areas 
mobilisation 
Aseptic 
mobilisation % 
(n = 13) 
SUVmax %
(n = 12a) 
Aseptic 
mobilisation % 
(n = 11) 
SUVmax % 
(n = 11) 
Control %
(n = 11) 
A1 46.2 (6/13) 16.7 (2/12) 18.2 (2/11) 9.1 (1/11) 0 
B 30.8 (4/13)  9.1 (1/11)  0 
C1 38.5 (5/13) 8.3 (1/12) 0  0 
A2 84.6 (11/13) 16.7 (2/12) 100 27.3 (3/11) 100 
C2 76.9 (10/13) 50 (6/12) 90.9 (10/11) 54.5 (6/11) 90.9 (10/11)
1 23.1 (3/13)  27.3 (3/11)  18.2 (2/11)
2 0  9.1 (1/11) 9.1 (1/11) 0 
3 0  0  0 
4 0  9.1 (1/11)  0 
5 0  0  0 
6 0  0  0 
7 7.7 (1/13)  9.1 (1/11)  0 
None 7.7 (1/13) 8.3 (1/12) 0  0 
aIn one of the aseptic mobilisations, only an emission study was carried out, so it was not 
possible to perform the quantification for the standardised uptake value. PET: positron 
emission tomography; SUVmax: maximum standardised uptake value. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Frequencies of the number of pet uptake areas in the hip prosthesis case group,   
maximum standardised uptake value and statistical relationship between subgroups          
(septic/aseptic mobilisation) 
Type  No. of areas THP P SUVmax THP P 
Aseptic mobilisation N 13  12  
 Mean 3 (min 0, max 7)  3.9 (min 0, max 8.5)  
 P25 2  2.1  
 P50 (median) 2  4.1  
 P75 4,50  5.20  
   0,955  0.740 
Septic mobilisation N 11  11  
 Mean 2.7 (min 2, max 5)  4.8 (min 2.6, max 13)  
 P25 2  2.9  
 P50 (median) 3  4  
 P75 3  4.7  
PET: positron emission tomography  
SUVmax: maximum standardised uptake value 
THP: hip prosthesis 
 
 
 
 
 
Table 3. Definitive diagnosis versus PETA diagnosis 
PET diagnosis by specialist 
 No 
infection
Possible 
infection 
Certain 
infection 
Total 
definitive
Aseptic mobilisation 8 1 4 13 Definitive diagnosis 
 Septic mobilisation 4 2 5 11 
Total specialist 12 3 9 24  
Sensitivity (Se) = 7/11 = 63.6 % (37.6 %; 85.6 %)     
Specificity (Sp) = 8/13 = 61.5 % (40.5 %; 84.3 %)     
Youden index = 0.25 (–0.05; 0.63)     
 
PET: positron emission tomography. 
 
 
 
 
 
 
 
 Table 4. Statistical parameters of our study 
 Sensitivity Specificity Youden index PPV NPV
Presurgical diagnosisa 78.6 100 0.79 100 97.45
Radiological periosteal detachment 64.3 76.5 0.41 25.05 94.69
18FDG-PET 63.6 61.5 0.25 58.3 66.6 
Neutrophil count (IBBF) > 5/hpf 78.57 100 0.79 100 97.45
aClinical-radiological laboratory. IBBF: intra operative biopsy by freezing; NPV: negative 
predictive value; PPV: positive predictive value; 18FDG-PET: positron emission tomography 
with fluorodeoxyglucose. 
 
 
 
 
Table 5. Sensitivity and specificity of pet in the diagnosis of prosthetic infectiona 
Study Cases No.infections tested Sensitivity Specificity 
Schnier et al,1998 34 (18 THP + 6 TKP)  100 95 
Love et al, 2000 31 (PTC + PTR) 11 100 55 
Zhuang et al, 2001 74 (total) 21 90,5 81,1 
 38 (THP) 10 90 (9/10) 89.3 (25/28) 
 36 ( TKP) 11 91 (10/11) 72 (19/25) 
Van Acker et al, 2001 21 ( TKP) 6 100 (6/6) 73 (7/11) 
Chako et al, 2002 41 (THP) 12 92 (11/12) 97 (28/29) 
Cremerius et al, 2003 18 (THP) 7 86 (6/7) 91 (10/11) 
Vanquickenborne et 
al, 2003 17 (THP) 8 87.5 77.8 
García et al, 2004 31 (24 THP + 7 TKP) 14 (3 TKP + 11 THP) 64.3 (9/14) 64.7 (11/17) 
 24 (THP) 11 63.6 (7/11) 61.5 (8/13) 
 7 ( TKP) 3 100 (3/3) 75 (3/4) 
aResults obtained from the joint study of 24 THP and 7 TKP are included in these results. 
THP: hip prosthesis; TKP: knee prosthesis. 
 
